Speciality: Oncology
Description:
Welcome to our podcast on Evidence-Based Oncology—a practice that’s transforming cancer care worldwide. Evidence-based oncology means making clinical decisions grounded in the latest and most reliable research, rather than tradition or anecdote. This approach ensures that patients receive treatments proven to be effective, personalised to their unique situations. By analysing large-scale clinical trials and real-world data, oncologists can identify which therapies work best for specific cancers and patient populations. Ultimately, evidence-based practice leads to better outcomes, fewer side effects, and more efficient use of healthcare resources. As research continues to advance, evidence-based oncology promises a future where every patient receives the right care at the right time.
See More Webinars @ Hidoc Webinars
1.
Depression risk higher among long-term breast cancer survivors than women without breast cancer history
2.
Infections the Main Cause of Nonrelapse Mortality After CAR-T for Blood Cancers
3.
PPI, Antibiotics May Curb Durvalumab Efficacy in NSCLC
4.
Herpes virus-based vaccine shows promise in targeting tumors without side effects
5.
Ranking of the Best US Hospitals for Psychiatric Care.
1.
New Frontiers in Diagnosing and Managing Myelodysplastic Syndromes (MASLD)
2.
Landmark Medical Oncology Trials Redefining Early Breast Cancer Management
3.
Strategic Applications in Hematology in Clinical Decision-Making
4.
Obesity is a major risk factor for cancer
5.
MASLD and Cancer Risk: Pathogenic Links and Clinical Implications Reviewed
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Efficient Management of First line ALK-rearranged NSCLC - Part VIII
2.
Evolution in Treatment and Diagnosis of Lung Cancer- An Initiative from Manipal Hospitals
3.
Oropharyngeal Cancer in Relation to HPV Status
4.
Evidence-Based Oncology
5.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part I
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation